|
ARNTL2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.17309999994697E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.35089999997451E-06 |
| Normal-vs-Stage2 |
2.898300E-02 |
| Normal-vs-Stage3 |
6.582900E-03 |
| Normal-vs-Stage4 |
2.551600E-01 |
| Stage1-vs-Stage2 |
6.137600E-01 |
| Stage1-vs-Stage3 |
7.860000E-01 |
| Stage1-vs-Stage4 |
5.109400E-01 |
| Stage2-vs-Stage3 |
5.485200E-01 |
| Stage2-vs-Stage4 |
4.771000E-01 |
| Stage3-vs-Stage4 |
6.805400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.06899999974664E-07 |
| Normal-vs-AfricanAmerican |
4.59630000004818E-06 |
| Normal-vs-Asian |
1.153420E-01 |
| Caucasian-vs-AfricanAmerican |
3.557000E-01 |
| Caucasian-vs-Asian |
6.118000E-01 |
| AfricanAmerican-vs-Asian |
3.861000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.69970000002606E-06 |
| Normal-vs-Female |
2.7610999997485E-07 |
| Male-vs-Female |
5.455200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.963600E-03 |
| Normal-vs-Extreme_Weight |
9.60450000000446E-05 |
| Normal-vs-Obese |
8.23040000000885E-05 |
| Normal-vs-Extreme_Obese |
7.426300E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.117000E-01 |
| Normal_Weight-vs-Obese |
1.817960E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.791800E-01 |
| Extreme_Weight-vs-Obese |
2.281200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.931400E-01 |
| Obese-vs-Extreme_Obese |
3.633400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.132100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.10350000248616E-08 |
| Normal-vs-Age(61-80Yrs) |
2.1400999999921E-05 |
| Normal-vs-Age(81-100Yrs) |
4.515600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.620400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.748800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.199630E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.132400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.95941999999727E-05 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.484720E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.69959999962721E-07 |
| Normal-VS-Type2 PRCC |
2.660400E-03 |
| Normal-VS-KIRP CIMP |
8.138800E-01 |
| Normal-VS-Unclassified PRCC |
4.36550000004754E-06 |
| Type1 PRCC-VS-Type2 PRCC |
7.543600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.012800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.682200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.331200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.161000E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.226090E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.935800E-03 |
| Normal-vs-N1 |
4.576400E-02 |
| Normal-vs-N2 |
6.748400E-02 |
| N0-vs-N1 |
2.467600E-01 |
| N0-vs-N2 |
1.024020E-01 |
| N1-vs-N2 |
2.078800E-01 |
|
|
